288 related articles for article (PubMed ID: 15010475)
1. Protease-activated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation.
Darmoul D; Gratio V; Devaud H; Laburthe M
J Biol Chem; 2004 May; 279(20):20927-34. PubMed ID: 15010475
[TBL] [Abstract][Full Text] [Related]
2. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation.
Darmoul D; Gratio V; Devaud H; Peiretti F; Laburthe M
Mol Cancer Res; 2004 Sep; 2(9):514-22. PubMed ID: 15383630
[TBL] [Abstract][Full Text] [Related]
3. P2Y receptor-mediated stimulation of Müller glial cell DNA synthesis: dependence on EGF and PDGF receptor transactivation.
Milenkovic I; Weick M; Wiedemann P; Reichenbach A; Bringmann A
Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1211-20. PubMed ID: 12601051
[TBL] [Abstract][Full Text] [Related]
4. Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2 alpha-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblasts.
Ahmed I; Gesty-Palmer D; Drezner MK; Luttrell LM
Mol Endocrinol; 2003 Aug; 17(8):1607-21. PubMed ID: 12738761
[TBL] [Abstract][Full Text] [Related]
5. Transactivation of the epidermal growth factor receptor mediates cholinergic agonist-induced proliferation of H508 human colon cancer cells.
Cheng K; Zimniak P; Raufman JP
Cancer Res; 2003 Oct; 63(20):6744-50. PubMed ID: 14583469
[TBL] [Abstract][Full Text] [Related]
6. The transactivated epidermal growth factor receptor recruits Pyk2 to regulate Src kinase activity.
Schauwienold D; Sastre AP; Genzel N; Schaefer M; Reusch HP
J Biol Chem; 2008 Oct; 283(41):27748-27756. PubMed ID: 18667434
[TBL] [Abstract][Full Text] [Related]
7. Dependence of gonadotropin-releasing hormone-induced neuronal MAPK signaling on epidermal growth factor receptor transactivation.
Shah BH; Soh JW; Catt KJ
J Biol Chem; 2003 Jan; 278(5):2866-75. PubMed ID: 12446705
[TBL] [Abstract][Full Text] [Related]
8. alpha 2B-adrenergic receptor activates MAPK via a pathway involving arachidonic acid metabolism, matrix metalloproteinases, and epidermal growth factor receptor transactivation.
Cussac D; Schaak S; Denis C; Paris H
J Biol Chem; 2002 May; 277(22):19882-8. PubMed ID: 11891218
[TBL] [Abstract][Full Text] [Related]
9. Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor.
Shah BH; Yesilkaya A; Olivares-Reyes JA; Chen HD; Hunyady L; Catt KJ
Mol Endocrinol; 2004 Aug; 18(8):2035-48. PubMed ID: 15143154
[TBL] [Abstract][Full Text] [Related]
10. Metabotropic glutamate receptor 5-induced phosphorylation of extracellular signal-regulated kinase in astrocytes depends on transactivation of the epidermal growth factor receptor.
Peavy RD; Chang MS; Sanders-Bush E; Conn PJ
J Neurosci; 2001 Dec; 21(24):9619-28. PubMed ID: 11739572
[TBL] [Abstract][Full Text] [Related]
11. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells.
Vacca F; Bagnato A; Catt KJ; Tecce R
Cancer Res; 2000 Sep; 60(18):5310-7. PubMed ID: 11016663
[TBL] [Abstract][Full Text] [Related]
12. TNF-α and LPA promote synergistic expression of COX-2 in human colonic myofibroblasts: role of LPA-mediated transactivation of upregulated EGFR.
Yoo J; Rodriguez Perez CE; Nie W; Sinnett-Smith J; Rozengurt E
BMC Gastroenterol; 2013 May; 13():90. PubMed ID: 23688423
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide inhibits angiotensin II-induced activation of the calcium-sensitive tyrosine kinase proline-rich tyrosine kinase 2 without affecting epidermal growth factor receptor transactivation.
Wang D; Yu X; Brecher P
J Biol Chem; 1999 Aug; 274(34):24342-8. PubMed ID: 10446212
[TBL] [Abstract][Full Text] [Related]
14. The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway.
Marques SA; Dy LC; Southall MD; Yi Q; Smietana E; Kapur R; Marques M; Travers JB; Spandau DF
J Pharmacol Exp Ther; 2002 Mar; 300(3):1026-35. PubMed ID: 11861812
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide-induced transactivation of a neuronal epidermal growth factor receptor is mediated by metalloprotease-dependent formation of heparin-binding epidermal growth factor.
Shah BH; Farshori MP; Catt KJ
J Biol Chem; 2004 Jan; 279(1):414-20. PubMed ID: 14573593
[TBL] [Abstract][Full Text] [Related]
16. Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells.
Venkatakrishnan G; Salgia R; Groopman JE
J Biol Chem; 2000 Mar; 275(10):6868-75. PubMed ID: 10702246
[TBL] [Abstract][Full Text] [Related]
17. Metalloproteinase-dependent transforming growth factor-alpha release mediates neurotensin-stimulated MAP kinase activation in human colonic epithelial cells.
Zhao D; Zhan Y; Koon HW; Zeng H; Keates S; Moyer MP; Pothoulakis C
J Biol Chem; 2004 Oct; 279(42):43547-54. PubMed ID: 15247267
[TBL] [Abstract][Full Text] [Related]
18. Transactivation of epidermal growth factor receptor is involved in leptin-induced activation of janus-activated kinase 2 and extracellular signal-regulated kinase 1/2 in human gastric cancer cells.
Shida D; Kitayama J; Mori K; Watanabe T; Nagawa H
Cancer Res; 2005 Oct; 65(20):9159-63. PubMed ID: 16230373
[TBL] [Abstract][Full Text] [Related]
19. Roles of Src and epidermal growth factor receptor transactivation in transient and sustained ERK1/2 responses to gonadotropin-releasing hormone receptor activation.
Shah BH; Farshori MP; Jambusaria A; Catt KJ
J Biol Chem; 2003 May; 278(21):19118-26. PubMed ID: 12642580
[TBL] [Abstract][Full Text] [Related]
20. Thrombin-induced p38 mitogen-activated protein kinase activation is mediated by epidermal growth factor receptor transactivation pathway.
Kanda Y; Mizuno K; Kuroki Y; Watanabe Y
Br J Pharmacol; 2001 Apr; 132(8):1657-64. PubMed ID: 11309236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
